AU2001256998A1 - Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death - Google Patents
Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell deathInfo
- Publication number
- AU2001256998A1 AU2001256998A1 AU2001256998A AU5699801A AU2001256998A1 AU 2001256998 A1 AU2001256998 A1 AU 2001256998A1 AU 2001256998 A AU2001256998 A AU 2001256998A AU 5699801 A AU5699801 A AU 5699801A AU 2001256998 A1 AU2001256998 A1 AU 2001256998A1
- Authority
- AU
- Australia
- Prior art keywords
- diagnosing
- disorders
- compositions
- methods
- cell death
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 2
- 230000030833 cell death Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000035475 disorder Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54793800A | 2000-04-11 | 2000-04-11 | |
US09547938 | 2000-04-11 | ||
PCT/US2001/011501 WO2001081361A1 (en) | 2000-04-11 | 2001-04-09 | Compositions and method for diagnosing and treating conditions, disorders, or diseases involving cell death |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001256998A1 true AU2001256998A1 (en) | 2001-11-07 |
Family
ID=24186756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001256998A Abandoned AU2001256998A1 (en) | 2000-04-11 | 2001-04-09 | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001256998A1 (en) |
WO (1) | WO2001081361A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050233413A1 (en) * | 2002-05-16 | 2005-10-20 | Ikuo Nishimoto | Neuroprotective polypeptides and methods of use |
WO2008153788A2 (en) | 2007-05-30 | 2008-12-18 | Albert Einstein College Of Medicine Of Yeshiva University | Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof |
WO2009033794A2 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of endothelin-1, optionally in combination with obestatin, as a therapeutic agent |
US8637470B2 (en) | 2008-05-01 | 2014-01-28 | The Regents Of The University Of California | Small humanin-like peptides |
US20220324911A1 (en) * | 2019-08-15 | 2022-10-13 | Cohbar, Inc. | Therapeutic peptides |
US20220306691A1 (en) * | 2019-08-15 | 2022-09-29 | Cohbar, Inc. | Therapeutic peptides |
US20220305079A1 (en) * | 2019-08-15 | 2022-09-29 | Cohbar, Inc. | Therapeutic peptides |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3665893A (en) * | 1992-02-12 | 1993-09-03 | United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The | Sequences characteristic of human gene transcription product |
-
2001
- 2001-04-09 AU AU2001256998A patent/AU2001256998A1/en not_active Abandoned
- 2001-04-09 WO PCT/US2001/011501 patent/WO2001081361A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001081361A8 (en) | 2002-02-28 |
WO2001081361B1 (en) | 2002-06-27 |
WO2001081361A1 (en) | 2001-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2085201A (en) | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death | |
WO2005046434A8 (en) | Compositions and methods for diagnosing and treating mental disorders | |
AU3998400A (en) | Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor | |
AU2003238561A1 (en) | Compositions and methods for treating gynaecological disorders | |
AU2001288271A1 (en) | Methods for treating inflammatory diseases | |
AU2001260847A1 (en) | Compositions isolated from skin cells and methods for their use | |
AU2001284865A1 (en) | Methods for diagnosing and treating dysautonomia and other dysautonomic conditions | |
WO2001079164A3 (en) | N-substituted dithiocarbamates for the treatment of biological disorders | |
AU2001251507A1 (en) | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death | |
ZA200003768B (en) | Methods and compositions for treating diseases and conditions of the eye. | |
AU2002235692A1 (en) | Methods and compositions for preventing and treating neutrophil-mediated diseases | |
MXPA03003741A (en) | Methods and compositions for the treatment of diseases of the eye. | |
WO2003039490A9 (en) | Compositions and methods for diagnosing and treating mental disorders | |
AU2001251508A1 (en) | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death | |
AU2001256998A1 (en) | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death | |
EP1670894B8 (en) | Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions | |
ZA200203435B (en) | Method and compositions for treating pulmonary diseases. | |
AU4515001A (en) | Compositions and methods for locally treating inflammatory diseases | |
AU2001283199A1 (en) | Methods and compositions for the diagnosis and treatment of brown adipose cell disorders | |
AU2002312314A1 (en) | Compositions and methods for preventing neural tube disorders | |
AU2003214920A1 (en) | Methods and compositions for treating hematological disorders | |
AU2001238288A1 (en) | Method and compositions for treating fibrotic diseases | |
AU2002316647A1 (en) | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death | |
AU2002217915A1 (en) | Compositions and methods for diagnosing or treating psoriasis | |
AU6385200A (en) | Compositions, kits, and methods for prognostication, diagnosis, prevention, and treatment of bone-related disorders and other disorders |